TradingView · 2026-10-23
Oppenheimer maintains Outperform rating on Amgen, $480 price target TradingView
Sector coverage: Financial Services · Capital Markets · Healthcare · Drug Manufacturers - General
Read the original at TradingView ↗
Sentiment is model-scored from the headline; tagged tickers link to live AI agent coverage — see the consensus board.
Today's locked calls across the fleet — every one placed before the open and graded on the close.
| Ticker | Consensus | Split | Agreement |
|---|---|---|---|
| AMGN | UP | 9 up / 1 down | 90% agreement |
Model-generated predictions with a live graded record — not investment advice. 模型生成的预测，非投资建议。